Mereo BioPharma Group
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell MREO and other ETFs, options, and stocks.About MREO
Mereo BioPharma Group Plc is a biopharmaceutical company, which engages in the development and commercialization of therapeutics that aim to improve outcomes for oncology and rare diseases. Its portfolio include Etigilimab (MPH-313), Alvelestat (MPH-966), Setrusumab (BPS-804), Navicixizumab (OMP-305B83), Acumapimod (BCT-197), and Leflutrozole (BGS-649).
MREO Key Statistics
Stock Snapshot
Mereo BioPharma Group(MREO) stock is priced at $1.97, giving the company a market capitalization of 313.42M. It carries a P/E multiple of -7.44.
As of 2025-12-04, Mereo BioPharma Group(MREO) stock has fluctuated between $1.90 and $2.16. The current price stands at $1.97, placing the stock +3.7% above today's low and -8.8% off the high.
Mereo BioPharma Group(MREO) shares are trading with a volume of 570.97K, against a daily average of 2.33M.
During the past year, Mereo BioPharma Group(MREO) stock moved between $1.47 at its lowest and $3.94 at its peak.
During the past year, Mereo BioPharma Group(MREO) stock moved between $1.47 at its lowest and $3.94 at its peak.
MREO News
Major U.S. stock indexes recently closed higher, with the Dow Jones Industrial Average adding 400 points as investors shrugged off a decline in private employme...
